AstraZeneca - M&A Summary and Business Overview

Life ScienceCompany

AstraZeneca M&A Summary

AstraZeneca has acquired 21 companies, including 8 in the last 5 years. A total of 6 acquisitions came from private equity firms. It has also divested 11 assets.

AstraZeneca’s largest acquisition to date was in 2020, when it acquired Alexion Pharmaceuticals for $39.0B. It’s largest disclosed sale occurred in 2016, when it sold AstraZeneca - Small Molecule Anti-Infective Business to Pfizer for $550M. AstraZeneca has acquired in 8 different US states, and 8 countries. The Company’s most targeted sectors include life science (90%) and medical products (6%).

AstraZeneca Business Overview

Where is AstraZeneca headquartered?

AstraZeneca is headquartered in Cambridge, United Kingdom.

What is AstraZeneca’s revenue?

AstraZeneca disclosed revenue of 45,811M USD for 2023 and 44,351M USD for 2022.

How many employees does AstraZeneca have?

AstraZeneca has 83,100 employees.

What sector is AstraZeneca in?

AstraZeneca is a life science company.

When was AstraZeneca founded?

AstraZeneca was founded in 1992.

M&A Summary

  • M&A Total Activity30
    • M&A Buy Activity19
    • M&A Sell Activity11
  • Total Sectors Invested 3
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 19
  • M&A Advisors 4

AstraZeneca

AstraZeneca Plc

1 Francis Crick Avenue Cambridge Biomedical Campus,
Cambridge, CB2 0AA
United Kingdom,
+44 20 3749 5000
www.astrazeneca.com

AstraZeneca is a global biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in several major disease areas, including oncology, cardiovascular, renal & metabolism, and respiratory & immunology. The Company's aim is to improve the health and quality of life of patients around the world through medicines, treatment solutions, and accessibility to healthcare. AstraZeneca is involved in both the research and development (R&D) and manufacturing of drugs to address critical areas of unmet medical need. AstraZeneca was founded in 1992 and is based in Cambridge, United Kingdom.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.4/yr) # 12 2 - 1 2 2 19
vol $28.8B $39.0B $320M $2.3B $3.5B $73.9B
Sell (0.0/yr) # 11 - - - - - 11
vol $1.4B $1.4B
  30

Most Recent M&A

Company Date Value Type
Fusion Pharmaceuticals, Inc. 2024-03-19 2.4B USD Add-on Acquisition
Hamilton, Ontario · www.fusionpharma.com
Amolyt Pharma SAS 2024-03-14 1.1B USD Add-on Acquisition
Ecully, France · www.amolytpharma.com
Gracell Biotechnologies, Inc. 2023-12-26 1.2B USD Add-on Acquisition
Suzhou, China · www.gracellbio.com
Icosavax, Inc. 2023-12-12 1.1B USD Add-on Acquisition
Seattle, Washington · www.icosavax.com
Neogene Therapeutics, Inc. 2022-11-29 320M USD Add-on Acquisition
Santa Monica, California · www.neogene.com
Alexion Pharmaceuticals, Inc. 2020-12-12 39.0B USD Add-on Acquisition
Boston, Connecticut · www.alexion.com
Dogma's Oral PCSK9 Inhibitor Program 2020-09-17 - Divestiture
Boxford, Massachusetts
Juvisé Pharmaceuticals - Arimidex & Casodex 2019-12-20 - Divestiture
Villeurbanne, France
AstraZeneca Plc - Alvesco, Omnaris and Zetonna Business 2018-11-06 350M USD Divestiture
London, United Kingdom
AstraZeneca Plc - Seroquel and Seroquel XR 2018-05-27 - Divestiture
London, United Kingdom
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Fusion Pharmaceuticals, Inc.    - Ipsen SA - IPN-1087 2021-04-01 1
Hamilton, Ontario · www.fusionpharma.com Paris, France
MedImmune LLC 2007-06-01 Spirogen Ltd. 2013-10-15 3
Gaithersburg, Maryland · www.medimmune.com London, United Kingdom · www.spirogen.com

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 17 (89%) 58.1B (79%) 7 (64%) 900M (64%)
Medical Products 1 (5%) 15.6B (21%) 3 (27%) 325M (23%)
Information Technology 1 (5%) 150M (< 1%) - -
Healthcare Services - - 1 (9%) 175M (13%)
Total 19 $73.9B 11 $1.4B

By Geo

State/Country Buy Value Sell Value
United States 10 64.2B 3 325M
  California 3 2.7B - -
  Washington 1 1.1B - -
  Texas 1 2.7B - -
  New Jersey 1 323M - -
  Massachusetts 1 - - -
  Maryland 1 15.6B - -
  Connecticut 1 39.0B - -
United Kingdom 2 360M 5 1.1B
Canada 2 2.4B - -
  Ontario 1 2.4B - -
France 1 1.1B 1 -
Sweden - - 2 -
China 1 1.2B - -
Germany 1 150M - -
Japan 1 575M - -
Netherlands 1 4.0B - -
Domestic 2 (11%) 360M (< 1%) 5 (45%) 1.1B (77%)
Cross-border 17 (89%) 73.5B (100%) 6 (55%) 325M (23%)
Total 19 $73.9B 11 $1.4B

Top M&A Advisors

Financial Deals
Evercore Group
2
Ondra LLP (Ondra Partners)
1
Centerview Partners
1
Legal Deals
Freshfields
1

Deal Values

buy # Total
> $1B 11 $72.2B
$100M to $1B 6 $1.7B
TOTAL $73.9B
Largest Alexion Pharmaceuticals, Inc.
$39.0B (2020-12-12)
sell # Total
$100M to $1B 4 $1.4B
TOTAL $1.4B
Largest AstraZeneca - Small Molecule Anti-Infective Business
$550M (2016-08-24)

M&A Connections

Deals
Acquired from
Investor(s)
21%
4 (21%)
Strategic(s)
21%
4 (21%)
Divested to
Strategic(s)
100%
11 (100%)

 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for AstraZeneca

Life Science Companies , United Kingdom Companies